Tag: Adalimumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Adalimumab

Biosimilar boom ahead: Patent expirations set to reshape the global biologics market

Added to Collection on: 2025-05-01 14:43:24

Tags for this article:

Pharmaceutical industry
Specialty drugs
Biotechnology
Biopharmaceuticals
Biosimilar
Immunosuppressants
Adalimumab
Generic drug
Trastuzumab
Pharmaceutical industry in India
Food and Drug Administration
Genentech

Click the tags to see associated articles and topics

View Article Details
Biosimilar Monoclonal Antibodies Market Know the Scope and Trends - openPR.com

Added to Collection on: 2025-05-16 14:59:59

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Immunology
Biosimilar
Adalimumab
Biopharmaceutical
Infliximab
Rituximab
Trastuzumab
Bevacizumab
Denosumab
Cetuximab
Ranibizumab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Global Large Molecule Drug Substance CDMO Market to see 9% CAGR with research push by 2030

Added to Collection on: 2025-06-04 14:12:46

Tags for this article:

Pharmacy
Biopharmaceuticals
Biotechnology
Biotechnology products
Pharmaceutical industry
Biosimilar
Samsung Biologics
Contract manufacturing organization
Food and Drug Administration
Adalimumab
Draft:Mabion
Biocon

Click the tags to see associated articles and topics

View Article Details
AbbVie's Resilient Growth Amid R&D Challenges - AInvest

Added to Collection on: 2025-07-04 19:38:23

Tags for this article:

AbbVie
Immunosuppressants
Adalimumab
Emraclidine
Pfizer
Biosimilar
Roche
United States

Click the tags to see associated articles and topics

View Article Details
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a ...

Added to Collection on: 2025-07-16 18:01:32

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Specialty drugs
Golimumab
Biopharmaceutical
Biosimilar
Adalimumab
Intas Pharmaceuticals
Bevacizumab
Ustekinumab
Bio-Thera Solutions
Thera Solutions, Ltd.
United States

Click the tags to see associated articles and topics

View Article Details
Decoding the biosimilar paradox: Policy reforms, increased transparency and patient education

Added to Collection on: 2025-07-26 02:50:12

Tags for this article:

Specialty drugs
Pharmacy
Biopharmaceuticals
Pharmaceuticals policy
Biosimilar
TNF inhibitors
Pharmacy benefit management
Adalimumab
Formulary
Express Scripts
Medication costs
Specialty pharmacy
Nicole Faucher

Click the tags to see associated articles and topics

View Article Details
Ankylosing Spondylitis Market Size to Hit USD 11.15 Billion - GlobeNewswire

Added to Collection on: 2025-08-21 13:53:46

Tags for this article:

Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Biotechnology
Biopharmaceutical
Ankylosing spondylitis
Adalimumab
Etanercept
Biosimilar
Infliximab
Spondyloarthritis

Click the tags to see associated articles and topics

View Article Details
Biosimilars Market to Surpass US$ 171.79 Billion by 2033 - Exclusive Report by DataM Intelligence

Added to Collection on: 2025-08-22 15:13:23

Tags for this article:

Specialty drugs
Monoclonal antibodies
Orphan drugs
Immunosuppressants
TNF inhibitors
Biosimilar
Biopharmaceutical
Biocon
Adalimumab
Rituximab
Trastuzumab
Bevacizumab

Click the tags to see associated articles and topics

View Article Details
FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars

Added to Collection on: 2025-09-02 20:28:54

Tags for this article:

Pharmaceutical industry
Specialty drugs
Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Biosimilar
Biopharmaceutical
Adalimumab
Sarfaraz K. Niazi
Generic drug
Food and Drug Administration
Association for Accessible Medicines

Click the tags to see associated articles and topics

View Article Details
Characteristics of patients who developed transient anti-adalimumab antibodies

Added to Collection on: 2025-09-24 18:45:32

Tags for this article:

Immunology
Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Biotechnology
Adalimumab
Autoimmunity
Rheumatology
Autoimmune disease

Click the tags to see associated articles and topics

View Article Details
Book a Demo